TY - JOUR
T1 - Post COVID-19 mental health symptoms and quality of life among COVID-19 frontline clinicians
T2 - a comparative study using propensity score matching approach
AU - Zhao, Yan Jie
AU - Xing, Xiaomeng
AU - Tian, Tengfei
AU - Wang, Qian
AU - Liang, Sixiang
AU - Wang, Zhe
AU - Cheung, Teris
AU - Su, Zhaohui
AU - Tang, Yi Lang
AU - Ng, Chee H.
AU - Sha, Sha
AU - Xiang, Yu Tao
N1 - Funding Information:
We thank Mr. Changshun Xu, Mr. Cunliang Wang and Mr. Yan Li and other staff in Beijing Hospital Authority who contributed to this study. We also thank all clinicians who participated in this study. The study was supported by the Beijing Municipal Administration of Hospitals Incubating Program (PX2018063), Beijing Municipal Science & Technology Commission (Z181100001718124), Beijing Talents Foundation (2017000021469G222), and the University of Macau (MYRG2019-00066-FHS; MYRG2022-00187-FHS).
Funding Information:
We thank Mr. Changshun Xu, Mr. Cunliang Wang and Mr. Yan Li and other staff in Beijing Hospital Authority who contributed to this study. We also thank all clinicians who participated in this study. The study was supported by the Beijing Municipal Administration of Hospitals Incubating Program (PX2018063), Beijing Municipal Science & Technology Commission (Z181100001718124), Beijing Talents Foundation (2017000021469G222), and the University of Macau (MYRG2019-00066-FHS; MYRG2022-00187-FHS).
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Background: The extent and severity of post-COVID-19 mental health symptoms among frontline clinicians are not clear. This study compared mental health symptoms (i.e., depression, anxiety, and insomnia symptoms) and global quality of life (QOL) after the first COVID-19 outbreak between the COVID-19 treating and non-COVID-19 treating frontline clinicians. Methods: This cross-sectional, comparative, convenient-sampling study was conducted between October 13 and 22, 2020, which was five months after the first COVID-19 outbreak in China was brought under control. The severity of depression, anxiety, insomnia symptoms, and global QOL of the clinicians were assessed using the Patient Health Questionnaire-9 items (PHQ-9), Generalized Anxiety Disorder Scale—7 items (GAD-7), Insomnia Severity Index (ISI), and the World Health Organization Quality of Life Questionnaire—brief version (WHOQOL-BREF), respectively. The propensity score matching (PSM) method was used to identify comparable COVID-19 treating and non-COVID-19 treating frontline clinicians. A generalized linear model (GLM) was used to assess the differences in PHQ-9, GAD-7, ISI, and QOL scores between the COVID-19 treating and non-COVID-19 treating frontline clinicians. Results: In total, 260 COVID-19 treating frontline clinicians and 260 matched non- COVID-19 treating frontline clinicians were included. Non-COVID-19 treating frontline clinicians experienced more frequent workplace violence (WPV) than the COVID-19 treating frontline clinicians (χ2 = 7.6, p = 0.006). COVID-19 treating frontline clinicians reported higher QOL compared to their non-COVID-19 treating frontline counterparts (b = 0.3, p = 0.042), after adjusting for WPV experience. COVID-19 treating and non- COVID-19 treating frontline clinicians reported similar PHQ-9, GAD-7, and ISI total scores (all p values > 0.05). Conclusion: This study did not reveal more severe post-COVID-19 mental health symptoms in COVID-19 treating frontline clinicians compared to non-COVID-19 treating frontline clinicians. It is possible that the implementation of timely and appropriate mental health, social and financial supports could have prevented the worsening of mental health symptoms among the COVID-19 treating frontline clinicians after the first COVID-19 outbreak in China.
AB - Background: The extent and severity of post-COVID-19 mental health symptoms among frontline clinicians are not clear. This study compared mental health symptoms (i.e., depression, anxiety, and insomnia symptoms) and global quality of life (QOL) after the first COVID-19 outbreak between the COVID-19 treating and non-COVID-19 treating frontline clinicians. Methods: This cross-sectional, comparative, convenient-sampling study was conducted between October 13 and 22, 2020, which was five months after the first COVID-19 outbreak in China was brought under control. The severity of depression, anxiety, insomnia symptoms, and global QOL of the clinicians were assessed using the Patient Health Questionnaire-9 items (PHQ-9), Generalized Anxiety Disorder Scale—7 items (GAD-7), Insomnia Severity Index (ISI), and the World Health Organization Quality of Life Questionnaire—brief version (WHOQOL-BREF), respectively. The propensity score matching (PSM) method was used to identify comparable COVID-19 treating and non-COVID-19 treating frontline clinicians. A generalized linear model (GLM) was used to assess the differences in PHQ-9, GAD-7, ISI, and QOL scores between the COVID-19 treating and non-COVID-19 treating frontline clinicians. Results: In total, 260 COVID-19 treating frontline clinicians and 260 matched non- COVID-19 treating frontline clinicians were included. Non-COVID-19 treating frontline clinicians experienced more frequent workplace violence (WPV) than the COVID-19 treating frontline clinicians (χ2 = 7.6, p = 0.006). COVID-19 treating frontline clinicians reported higher QOL compared to their non-COVID-19 treating frontline counterparts (b = 0.3, p = 0.042), after adjusting for WPV experience. COVID-19 treating and non- COVID-19 treating frontline clinicians reported similar PHQ-9, GAD-7, and ISI total scores (all p values > 0.05). Conclusion: This study did not reveal more severe post-COVID-19 mental health symptoms in COVID-19 treating frontline clinicians compared to non-COVID-19 treating frontline clinicians. It is possible that the implementation of timely and appropriate mental health, social and financial supports could have prevented the worsening of mental health symptoms among the COVID-19 treating frontline clinicians after the first COVID-19 outbreak in China.
UR - http://www.scopus.com/inward/record.url?scp=85138127697&partnerID=8YFLogxK
U2 - 10.1038/s41398-022-02089-4
DO - 10.1038/s41398-022-02089-4
M3 - Journal article
C2 - 36085292
AN - SCOPUS:85138127697
SN - 2158-3188
VL - 12
JO - Translational Psychiatry
JF - Translational Psychiatry
IS - 1
M1 - 376
ER -